Lotrel (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Lotrel drug offered from Novartis Pharmaceuticals Corporation. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | amlodipine besylate and benazepril hydrochloride |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-03-03 |
| END MARKETING DATE: | 0000-00-00 |
Lotrel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lotrel from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 10(mg/1; mg/1) |
| START MARKETING DATE: | 1995-03-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0404_777600eb-081c-41de-af87-7bdda7c267b8 |
| PRODUCT NDC: | 0078-0404 |
| APPLICATION NUMBER: | NDA020364 |
Other AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
